# Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated Cirrhosis

> **NCT07755059** · NA · NOT_YET_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Ascites
- Liver Cirrhosis
- Hypertension, Portal

## Interventions

- **DEVICE:** Proximal Splenic Artery Embolization

## Key facts

- **NCT ID:** NCT07755059
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2030-04-01
- **Final completion:** 2030-10-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07755059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07755059, "Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated Cirrhosis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07755059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*